Document is current
Any future updates will be listed below
-
Authors
Palao-Ocharan, Paola https://orcid.org/0000-0001-6759-9503
Prior, Nieves
Pérez-Fernández, Elia https://orcid.org/0000-0003-2726-8683
Caminoa, Magdalena
,
Aberer, W.
Betschel, S.
Bygum, A.
Campos, R. A.
Csuka, D.
Farkas, H.
Gómez-Traseira, C.
Grumach, A. S.
Leibovich, I.
Malbran, A.
Moldovan, D.
Mihaly, E.
Obtulowicz, K.
Porebski, G.
Reshef, A.
Staubach, P.
Caballero, Teresa https://orcid.org/0000-0003-3005-9858
-
Funding
Funding for this research was provided by:
Fondo de Investigaciones Sanitarias (PI060843)
- License Information
-
More Information
Article History
Received: 20 September 2021
Accepted: 30 January 2022
First Online: 2 March 2022
Declarations
:
: The study was reviewed and approved by the Clinical Research Ethics Committee of La Paz University Hospital (Madrid, Spain) (PI-281 and PI-1881) and the committees of the participating hospitals from every country, according to their specific regulations.
: Not applicable.
: Dr. Paola Palao-Ocharan, Dr. Nieves Prior, Elia Pérez-Fernández declare that they have no competing interests. Dr. Magdalena Caminoa, reports grant from Fondo de Investigación Sanitaria (Health Ministry Spain), during the conduct of the study. Dr. Teresa Caballero, reports grants from Fondo de Investigación Sanitaria (Health Ministry Spain), during the conduct of the study; personal fees and other from BioCryst, personal fees, non-financial support and other from CSL-Behring, personal fees from Merck, personal fees and other from Novartis, personal fees from Octapharma, personal fees, non-financial support and other from Shire HGT, personal fees and other from harming NV, outside the submitted work.
